Becker Muscular Dystrophy (BMD) is a neuromuscular disorder and a milder allelic variant of Duchenne Muscular Dystrophy (DMD).
It is caused by mutations at Xp21 on the X chromosome β producing reduced, partially functional dystrophin.
π This leads to slower progression and later onset compared to DMD.
- X-linked recessive inheritance (affects males, females are carriers). π¨βπ¦±
- Dystrophin deficiency β fragile muscle fibres, repeated injury and degeneration.
- BMD patients often survive into adulthood, unlike DMD. β³
π§ββοΈ Clinical Presentation
- Progression: Similar to DMD but slower; ambulation often preserved into teens or 20s.
- Weakness: Proximal muscle weakness (hips, shoulders) β difficulty climbing stairs, running, or rising from the floor (Gowerβs sign). πͺ
- Pain & Cramps: Exercise-related myalgia and cramps are common.
- Physical Findings: Calf enlargement (pseudo-hypertrophy) and progressive proximal wasting.
- Cardiac Involvement: Dilated cardiomyopathy and arrhythmias may precede severe skeletal weakness. β€οΈ
π Investigations
- Creatine Kinase (CK): Elevated 10β100Γ above normal (marker of muscle breakdown). π§ͺ
- ECG & Echocardiogram: Early screening for cardiomyopathy and conduction defects.
- Electromyography (EMG): Myopathic pattern (small, polyphasic motor units) β distinguishes from neuropathic causes.
- Muscle Biopsy: Shows dystrophic changes with reduced (but not absent) dystrophin on immunohistochemistry. π§«
- Genetic Testing: Confirms dystrophin gene mutation; distinguishes from DMD (frame rule: out-of-frame = DMD, in-frame = BMD).
π Management
- Multidisciplinary care is essential (neurology, cardiology, physiotherapy, respiratory). π₯
- Physiotherapy & Exercise: Stretching & orthoses to reduce contractures and maintain mobility.
- Cardiac Monitoring: ACE inhibitors, Ξ²-blockers if cardiomyopathy develops.
- Respiratory Care: Non-invasive ventilation for advanced respiratory weakness.
- Orthopaedic Support: Correct scoliosis or postural deformities if present.
- Genetic Counselling: X-linked inheritance β carrier testing & family planning advice.
π Prognosis
- Slower progression than DMD, but eventual loss of ambulation common by mid-20s to 40s.
- Cardiac disease is the major cause of morbidity and mortality. β οΈ
- Many patients live into middle age with good supportive care.
π‘ Exam Pearls
β’ BMD vs DMD: DMD = absent dystrophin, early severe disease. BMD = reduced dystrophin, slower course.
β’ Key clue: Male adolescent with calf pseudo-hypertrophy + high CK.
β’ Cause of death: Cardiomyopathy > respiratory failure.
π References